Navigation Links
Biopharm Insight Hosts Educational Webinar Ahead of American Society of Hematology Conference Next Month
Date:11/13/2013

Norwood, MA (PRWEB) November 13, 2013

BioPharm Insight, a division of Infinata, will host an educational webinar to unveil highlights ahead of the American Society of Hematology (ASH) Annual Conference next month. The ASH Conference takes place December 7-10 in New Orleans.

Webinar: BioPharm Insight’s Pre-ASH Crash Course
Speaker: Juliana Wexler, Oncology Reporter
Date & Time: November 21, 10:00 AM EST
Register: http://goo.gl/5ij5j9

The webinar will cover:

  •     Celgene’s Revlimid - MM-020 and MM-015 trial results in newly-diagnosed multiple myeloma (MM)
  •     Array Biopharma’s ARRY-520 Phase Ib results in relapsed/refractory MM
  •     Antibodies in MM, including Genmab/Janssen’s daratumumab
  •     Ambit BioSciences’ quizartinib in AML
  •     MDS update with Array’s ARRY-614, Astex's SGI-110
  •     HDAC inhibitors development for MDS and MM
  •     B-cell inhibitors in CLL -- Gilead’s idelalisib, Pharmacyclics’ ibrutinib, Infinity’s IPI-145

Juliana Wexler specializes in cancer coverage for BioPharm Insight. Previously she was an HIV public health advocate at Jacobi Medical Center in New York, where she was involved in both research and recruiting participants for clinical trials. She has also been a research assistant at both Columbia University, as well as the University of Michigan. Juliana graduated with an individualized Bachelor’s in Health Care and Health Disparities from the University of Michigan.

About BioPharm Insight
BioPharm Insight is part of Infinata, a Financial Times Group company, and a leading provider of business intelligence solutions which also include BioPharm Clinical™, High Net Worth Insight™ and wealthmonitor™. BioPharm Insight provides subscribers with an information edge by combining the most comprehensive real-time database of companies, drugs, contacts, M&A and licensing deals, forecasts and clinical trial data with proprietary forward-looking intelligence uncovered by an independent team of investigative journalists months or even years before it breaks in mainstream media. To learn more, visit http://www.biopharminsight.com.

About Infinata, Inc.
Infinata provides personalized technology solutions to turn information into insight. Services include a comprehensive BioPharm Solutions Suite, unique Wealth Prospecting tools and innovative Custom Data Services. Infinata is a part of Mergermarket, a Financial Times Group company and a division of Pearson plc. To learn more, visit http://www.infinata.com.

Business Inquiries: Holly Burke, hburke[at]infinata[dot]com, 781-619-0131
Media Inquiries: Brenda Nashawaty, Brenda[at]nashawaty[dot]com, 617-688-3253

Read the full story at http://www.prweb.com/releases/2013/11/prweb11325293.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Biopharmaceuticals - A Global Market Overview
2. Biopharm Insight’s Respiratory Disease Report Highlights Key Drugs Coming Up for Approval or in Late-Stage Development
3. Mass Spectrometry Marketplace Discussed by Biopharm Reports in In-demand Research Study Available at MarketPublishers.com
4. World Antibiotic Resistance Market Saw Big Changes in Last Five Years, According to Biopharm Reports Study Available at MarketPublishers.com
5. Therapure Biopharma Inc. Awarded US Government Contract for Development of Anti-Nerve Gas Agent
6. Monoclonal Antibodies Market Dealmaking in Biopharma Industry Analyzed in New Research Report at ReportsnReports.com
7. BioPharm Systems Unveils Study Data Mapper to Simplify the Preparation and Reporting of Clinical Data
8. Nine Lives Media Names BioPharm Systems to the MSPmentor 501
9. BioPharm Systems to Host Webinar on Clinical Trial Supply Management with Siebel CTMS
10. BioPharm Systems to Host Webinar on Using iHelp in Oracle’s Siebel Clinical Trial Management System
11. BioPharm Systems Named to the 2012 Lead411 Technology 200 List
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... Plano, TX (PRWEB) , ... July 27, 2017 ... ... technology and outsourced services, announces the internal promotion of Elrene Clinkscales to Vice ... Operations – Claims & Remittance Management, reporting to Derek Morkel, chief executive officer ...
(Date:7/27/2017)... ... 2017 , ... Team Novo Nordisk, the world’s first all-diabetes professional cycling team, ... a stagiaire for the remainder of the 2017 season. One of our best development ... Tour of Utah. , “Every season we are excited to move an athlete from ...
(Date:7/26/2017)... ... July 26, 2017 , ... Written By: Ashley D. Beall, ... in drug therapy for patients living with relapsing and primary multiple sclerosis that ... cell targeted therapy that has been proven to significantly reduce signs of disease ...
(Date:7/26/2017)... ... July 26, 2017 , ... “We are dentists and we thought there ... Jose, Calif., “so we invented the MAGNETIC/ LOCK BRACKETS.” , The patent-pending MAGNETIC/ LOCK ... In doing so, it offers an effective alternative to traditional braces. As a result, ...
(Date:7/26/2017)... ... July 26, 2017 , ... “We are thrilled to be ... for patients to schedule an appointment online in real time,” said Keith English, LocalMed ... Smiles provider directory will bring more Six Month Smiles patients to their providers.” , ...
Breaking Medicine News(10 mins):
(Date:7/27/2017)...  West Pharmaceutical Services, Inc. (NYSE: WST ... 2017 and updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, ... Net sales at constant currency (organic) grew by 3.9%. ... compared to $0.60 in the prior-year quarter. Second-quarter 2017 ...
(Date:7/26/2017)... Aesthetics, a leading medical aesthetic clinic in Singapore ... skin conditions from the inside. The natural process of ... skin becomes more transparent due to the thinning of the epidermis. Over ... the sun contributes to aging skin, causing age spots and other ... ...
(Date:7/26/2017)... 26, 2017 The Galien Foundation announced ... USA Award Nominees. Counted among the global ... recognizes outstanding biomedical and technology product achievement that improves the ... qualify, each candidate must be U.S. Food and Drug Administration ... demonstrate tremendous potential to impact human health. Sales data are ...
Breaking Medicine Technology: